CRHR1 and Adrenal insufficiency: These results suggest that chronic treatments of CRF-R1 antagonists (at doses for which acute administration is effective to inhibit ACTH release) would neither hamper HPA axis activity nor induce adrenal insufficiency in non-stressed conditions.